These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31244937)

  • 1. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
    Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
    Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy.
    Wang W; Chen K; Su Y; Zhang J; Li M; Zhou J
    Biomacromolecules; 2018 Feb; 19(2):438-448. PubMed ID: 29334216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo.
    Salmasi Z; Hashemi M; Mahdipour E; Nourani H; Abnous K; Ramezani M
    Biotechnol Prog; 2020 Nov; 36(6):e3025. PubMed ID: 32410328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
    Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
    Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic ternary nanohybrids for nonviral gene delivery of stem cells and applications on cancer therapy.
    Huang RY; Lin YH; Lin SY; Li YN; Chiang CS; Chang CW
    Theranostics; 2019; 9(8):2411-2423. PubMed ID: 31149052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
    Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
    Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy.
    Han J; Hwang HS; Na K
    Biomaterials; 2018 Nov; 182():259-268. PubMed ID: 30142525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour.
    Fakiruddin KS; Ghazalli N; Lim MN; Zakaria Z; Abdullah S
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
    Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
    Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
    Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
    Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.
    Loebinger MR; Eddaoudi A; Davies D; Janes SM
    Cancer Res; 2009 May; 69(10):4134-42. PubMed ID: 19435900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinspired Star-Shaped Poly(l-lysine) Polypeptides: Efficient Polymeric Nanocarriers for the Delivery of DNA to Mesenchymal Stem Cells.
    Walsh DP; Murphy RD; Panarella A; Raftery RM; Cavanagh B; Simpson JC; O'Brien FJ; Heise A; Cryan SA
    Mol Pharm; 2018 May; 15(5):1878-1891. PubMed ID: 29590755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.
    Moniri MR; Sun XY; Rayat J; Dai D; Ao Z; He Z; Verchere CB; Dai LJ; Warnock GL
    Cancer Gene Ther; 2012 Sep; 19(9):652-8. PubMed ID: 22767216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
    J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL.
    Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA
    Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy.
    Zhang F; Li M; Su Y; Zhou J; Wang W
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():208-218. PubMed ID: 27127046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.